|
⚲
|
| Keyboard |
| D'silva Andrew J
✚
|
|
|---|---|
| CIK # | 0002083717 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002083717] | |
| 4 | [0002083717] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| OptimizeRx Corp | |
| D'silva Andrew J |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
OptimizeRx Corp OPRX
Common Stock
|
2025-12-19 | Tax withheld | 703 | $13.51 | 9,498 |
|
OptimizeRx Corp OPRX
Common Stock
|
2025-12-11 | Tax withheld | 868 | $14.03 | 12,178 |
|
OptimizeRx Corp OPRX
Common Stock
|
2025-10-03 | Tax withheld | 794 | $18.75 | 14,888 |
|
OptimizeRx Corp OPRX
Common Stock
|
2025-10-01 | Tax withheld | 414 | $18.98 | 7,858 |
|
OptimizeRx Corp OPRX
Common Stock
|
2025-08-21 | Grant | 10,417 | $0.00 | |
|
OptimizeRx Corp OPRX
Stock Option · derivative
|
2025-08-21 | Grant | 23,437 | $0.00 |